SPONSOR
Medical University of Silesia
Total Trials
2
Recruiting
2
Phases
Phase 4
Medical University of Silesia is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Ischemic Stroke, Atrial Fibrillation, Chronic Kidney Disease, Cardiovascular Diseases.
The trial portfolio spans Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Medical University of Silesia
How many clinical trials has Medical University of Silesia sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Medical University of Silesia, of which 2 are actively recruiting participants. These trials cover conditions including Ischemic Stroke, Atrial Fibrillation, Chronic Kidney Disease. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Medical University of Silesia research focus on?
Medical University of Silesia clinical trials span Ischemic Stroke, Atrial Fibrillation, Chronic Kidney Disease, Cardiovascular Diseases. The research pipeline includes Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Medical University of Silesia clinical trial?
To participate in a Medical University of Silesia trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Medical University of Silesia trials with current recruitment status updated daily.
Clinical Trials by Medical University of Silesia
NCT06212674 Phase 4
Recruiting
Single-stage Pulmonary Vein Isolation Combined With Percutaneous Left Atrial Appendage Occluder Implantation in Patients With Recent Onset Ischemic Stroke and Atrial Fibrillation
Ischemic Stroke
NCT06083168
Recruiting
Cardiovascular Disease in Patients With Chronic Kidney Disease: Polish Kidney- Heart Project
Chronic Kidney Disease
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology